GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2819.00-1.85 (-0.07 %)
PREV CLOSE (Rs.) 2820.85
OPEN PRICE (Rs.) 2810.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1599
TODAY'S LOW / HIGH (Rs.)2780.50 2825.00
52 WK LOW / HIGH (Rs.)1924.3 3515.95
NSE2820.601.5 (+0.05 %)
PREV CLOSE( Rs. ) 2819.10
OPEN PRICE (Rs.) 2819.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2820.60 (254)
VOLUME 55776
TODAY'S LOW / HIGH(Rs.) 2780.00 2824.90
52 WK LOW / HIGH (Rs.)1921 3515.7

Company Information

ChairmanRenu Sud Karnad
Managing DirectorBhushan Akshikar
Company SecretaryAjay Nadkarni
Non Executive DirectorS Williams
Non Executive Independent DirectorManu Anand
Sunita Maheshwari
P R Somasundaram
Anup Wadhawan
Whole Time DirectorJuby Chandy
Incorporation Year : 13-11 1924
Registered Office :
Gsk House, Dr. Annie Besant Road,Worli, Mumbai,
Maharashtra-400030 .
Phone :
022-24959595  
E-mail :
askus@gsk.com / in.investorquery@gsk.com
URL
www.gsk-india.com
Industry :
Pharmaceuticals & Drugs  
Listing :
BSE,NSE  

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015
Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.
© 2015 FRR Shares. All Rights Reserved | Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
close X

Download Client Registration Documents